PSMB8作为直肠癌术前放疗反应候选标志物
研究比较22例局部晚期直肠癌(LARC)患者术前放化疗(CRT)应答者与非应答者的肿瘤基因表达谱,发现8个差异表达基因(P<.0005)。在额外40例LARC患者中,RT-PCR验证PSMB8和SLC39A7在应答组上调。体外和体内实验表明PSMB8过表达增强放射敏感性,提示PSMB8是术前放射敏感性的预测标志物,需更大队列临床验证。
要点
- RNA-Seq发现8个与LARC术前CRT反应相关的差异表达基因(>16倍,P<.0005)。
- 在40例LARC验证队列中,PSMB8和SLC39A7在应答组上调。
- PSMB8过表达增强CRC细胞和异种移植瘤的放射敏感性。
核心结论
- PSMB8是LARC患者术前放射敏感性的预测标志物,需更大队列临床验证。
研究设计与样本
- 对22例LARC患者(应答9例,非应答13例)的肿瘤基线基因表达谱进行RNA测序分析。
- 在额外40例LARC患者(应答20例,非应答20例)的肿瘤样本中用实时RT-PCR验证RNA-Seq发现。
- 在结直肠癌细胞系中稳定过表达或敲低候选基因,体外及小鼠异种移植模型测试放射反应。
主要发现
- 鉴定出8个差异表达>16倍且与术前CRT反应相关的基因:B3GALT4、HSPA1B、KRBOX1、PPBP、PPP1R18、PSMB8、SLC39A7和TAP2(P<.0005)。
- 在额外40例LARC患者中,实时RT-PCR显示PSMB8和SLC39A7在应答组上调。
- CRC细胞系中,PSMB8过表达在6 Gy照射后显著减少集落形成并增加凋亡诱导分子cleaved caspase-3和cleaved PARP。
- PSMB8敲低在照射后增加集落形成并降低caspase-3活化和cleaved PARP水平。
- SLC39A7过表达对受照射CSC细胞无显著影响;照射后,过表达PSMB8的HCT116异种移植瘤生长慢于空载体对照。
临床怎么用
- PSMB8或可作为预测LARC患者术前放疗敏感性的候选标志物,但尚需更大队列临床验证。
局限性
- 结论基于较小样本(RNA-Seq 22例,验证40例),需更大队列临床验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The ability to predict individual responsiveness to cancer therapy is urgently needed. This is particularly true for patients with locally advanced rectal cancer (LARC) because a large proportion are resistant to preoperative chemoradiation therapy (CRT). In this study, we sought to identify markers that could predict response by comparing the gene expression profiles of the tumors of patients who received preoperative CRT. METHODS AND MATERIALS: The basal gene expression profiles of tumors from 22 LARC patients who were responders (n=9) and nonresponders (n=13) to preoperative CRT were analyzed using RNA sequencing (RNA-Seq). To validate the RNA-Seq findings, real-time reverse transcriptase polymerase chain reaction (RT-PCR) was performed on tumor samples from an additional 40 LARC patients (n=20 responders; n=20 nonresponders). Candidate genes were stably overexpressed or knocked down in colorectal cancer (CRC) cell lines, and the effect on response to radiation was tested in vitro and also in vivo in a mouse xenograft model. RESULTS: Eight differentially expressed (>16-fold) genes (B3GALT4, HSPA1B, KRBOX1, PPBP, PPP1R18, PSMB8, SLC39A7, and TAP2) associated with the preoperative CRT response were identified (P<.0005). Among these genes, real-time RT-PCR showed that PSMB8 and SLC39A7 were upregulated in the responsive group of the additional 40 LARC patients. In CRC cell lines, PSMB8 overexpression significantly reduced colony formation and increased the apoptosis-inducing molecules cleaved caspase-3 and cleaved PARP after 6-Gy irradiation. PSMB8 knockdown increased colony formation and decreased caspase-3 activation and cleaved PARP levels after irradiation. SLC39A7 overexpression had no significant effects on irradiated CSC cells. After irradiation of the xenografted mice, tumors that arose from CRC cell line HCT116 overexpressing PSMB8 grew more slowly than did those from HCT116 with vector alone. CONCLUSION: These results suggest that PSMB8 is a predictive marker of preoperative radiosensitivity in LARC patients. Clinical validation in a larger cohort is now required.
引用
- Ha YJ, Tak KH, Kim CW, et al. PSMB8 as a Candidate Marker of Responsiveness to Preoperative Radiation Therapy in Rectal Cancer Patients. Int J Radiat Oncol Biol Phys. 2017. PMID: 28721901. doi:10.1016/j.ijrobp.2017.03.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。